(MnZn)Fe/sub 2/O/sub 4/:MoO/sub 3/
Vancomycin-modified Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>@Ag microflowers as effective antimicrobial agents
... Van/Fe 3 O 4 @SiO 2 @Ag microflower with enhanced antibacterial activity is experimentally and theoretically presented in this ...Van/Fe 3 O 4 @SiO 2 ...
18
Ultrasmall superparamagnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles: honey-based green and facile synthesis and in vitro viability assay
... work, Fe 3 O 4 -NPs are synthesized using iron (III) chloride, iron (II) chloride, sodium hydroxide and natural honey at room temperature through a fast precipitation ...of Fe 3 ...
9
In vitro and in vivo targeting imaging of pancreatic cancer using a Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoprobe modified with anti-mesothelin antibody
... In this study, all the mice were successfully developed into subcutaneously transplanted tumor models. When the diam- eter of subcutaneously transplanted tumor reached 1.0 cm, nine mice were divided into three groups ...
13
The effects of magnetite (Fe<sub>3</sub>O<sub>4</sub>) nanoparticles on electroporation-induced inward currents in pituitary tumor (GH<sub>3</sub>) cells and in RAW 264.7 macrophages
... Figure 4, when cells were exposed to Fe 3 O 4 NPs (100 µ g/mL), there was a progressive decrease in the activity of MEP-induced channels, which occurred at the level of hyperpolarizing ...
10
Inhibitory effect of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles coloaded with homoharringtonine on human leukemia cells in vivo and in vitro
... magnetic Fe 3 O 4 nanoparticles (MNP-Fe 3 O 4 ) to improve the therapeutic effect of HHT and investigated its biological ...HHT-MNP-Fe 3 O ...
10
Characteristics of magnetic labeling on liver tumors with anti-alpha-fetoprotein-mediated Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles
... Abstract: For preoperative and intraoperative detection of tumor distribution, numerous multi- modal contrast agents, such as magnetic nanoparticles (MNPs) with several examination indicators, are currently in ...
10
Preparation and in vitro evaluation of doxorubicin-loaded Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles modified with biocompatible copolymers
... that Fe 3 O 4 -PLGA-PEG 2000 -doxorubicin has dose-dependent and time-dependent cytotoxicity against the A549 lung can- cer cell line (IC 50 ...that Fe 3 O 4 ...
16
Effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and wogonin on the reversal of multidrug resistance in K562/A02 cell line
... TRIzol. 4 µg of total RNA was added to reverse transcriptase buffer, 25 mmol/L of MgCl 2 , 10 mmol/L deoxyribonucleotide triphosphates, random 9 mers (50 pmol/ µ L), RNase inhibitor (40 U/ µ L), and avian ...
10
Magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and chemotherapy agents interact synergistically to induce apoptosis in lymphoma cells
... MNP-Fe 3 O 4 obtained from the State Key Laboratory of Bioelectronics, Southeast University, Nanjing, China, were well distributed in RPMI 1640 medium (Invitrogen, Carlsbad, CA) containing 10% ...
6
Effect of Fe<sub>3</sub>O<sub>4</sub>-magnetic nanoparticles on acute exercise enhanced KCNQ<sub>1</sub> expression in mouse cardiac muscle
... Forty-two mice were randomly assigned to either the non- exercised control group (n = 6) or exercise groups (n = 36). Thirty-six mice were placed into plastic cylinders (23 cm tall × 14 cm diameter) containing water ...
8
Fe<sub>3</sub>O<sub>4</sub>/Au magnetic nanoparticle amplification strategies for ultrasensitive electrochemical immunoassay of alfa-fetoprotein
... Cyclic voltammetry measurements were performed using an electrochemical analyzer CHI 660 (Shanghai Chenhua Instrumental Corp, China) connected to a personal com- puter. A three-compartment electrochemical cell contained ...
11
Synergistic effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> with gambogic acid on apoptosis of K562 leukemia cells
... of Fe 3 O 4 (MNPs-Fe 3 O 4 ...MNPs-Fe 3 O 4 dramati- cally enhanced GA-induced cytotoxicity and apoptosis in K562 ...MNPs-Fe ...
9
Effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4 </sub>and 5-bromotetrandrine on reversal of multidrug resistance in K562/A02 leukemic cells
... Human chronic myeloid leukemia in blast crisis cell line, K562, and its resistant cell line to ADM, K562/A02, were both cultured in a RPMI 1640 medium (Gibco/BRL, Gaithersburg, MD, USA) supplemented with 10% fetal calf ...
8
Molecular study of wound healing after using biosynthesized BNC/Fe<sub>3</sub>O<sub>4</sub> nanocomposites assisted with a bioinformatics approach
... of Fe 3 O 4 NPs into new iso- lated BNC fibrous membrane have been successfully devel- oped through a completely green ...spherical Fe 3 O 4 NPs were uniformly ...
17
Prevention of acute graft-versus-host disease by magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> combined with cyclosporin A in murine models
... with Fe 3 O 4 MNPs; otherwise, there were no differences in lung, kidney, and brain, suggesting that Fe 3 O 4 MNPs can increase the concentration of CsA in blood ...
7
Reversal of multidrug resistance by magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice
... nologies, Carlsbad, CA, USA) according to the manu- facturer’s protocol. One microgram of total RNA was used to generate cDNA using SuperScript™ II reverse transcriptase (Invitrogen Life Technologies). PCR primers were ...
6
Synergistic effect of a combination of nanoparticulate Fe<sub>3</sub>O<sub>4</sub> and gambogic acid on phosphatidylinositol 3-kinase/Akt/Bad pathway of LOVO cells
... CA). Fe 3 O 4 mag- netic nanoparticles (State Key Laboratory of Bioelectronics, Nanjing, China) were well distributed in RPMI 1640 medium containing 10% (v/v) heat-inactivated new-born calf ...
10
The reversal effect of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles loaded with cisplatin on SKOV3/DDP ovarian carcinoma cells
... MNPs- Fe 3 O 4 , and MNPs-Fe 3 O 4 loaded with DDP or RPMI-1640 were added into these cells and cultured to measure their growth and ...MNPs-Fe 3 ...
8
Co-encapsulation of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery
... Abstract: In this study, the authors constructed a novel PLGA [poly(D,L-lactic-co-glycolic acid)]-based polymeric nanocarrier co-encapsulated with doxorubicin (DOX) and magnetic Fe 3 O 4 ...
12
Effects of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> combinated with gambogic acid on apoptosis of SMMC-7721 cells
... of Fe 3 O 4 -MNP and GA on apoptosis induction in SMMC-7721 ...that Fe 3 O 4 -MNP at less than 20 μ g/mL concentration had no obvious influence on the ...
6